3-(Trifluoromethoxy)benzonitrile | CAS:52771-22-9

We serve 3-(Trifluoromethoxy)benzonitrile CAS:52771-22-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-(Trifluoromethoxy)benzonitrile

Chemical Name:3-(Trifluoromethoxy)benzonitrile
CAS.NO:52771-22-9
Synonyms:3-(Trifluoromethoxy)benzonitrile
m-(Trifluoromethoxy)benzonitrile
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 178.1±40.0 °C at 760 mmHg
Molecular Formula C8H4F3NO
Molecular Weight 187.119
Flash Point 61.5±27.3 °C
Vapour Pressure 1.0±0.3 mmHg at 25°C
Index of Refraction 1.461
 
Specification:
Appearance:Colorless to Almost colorless clear liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 3-(Trifluoromethoxy)benzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,m-(Trifluoromethoxy)benzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,m-(Trifluoromethoxy)benzonitrile Use and application,3-(Trifluoromethoxy)benzonitrile technical grade,usp/ep/jp grade.


Related News: “So far, the finding is still under preliminary study, and a large number of experiments is needed to test if it is effective on patients,” it said, citing the WHO in saying that no proven effective drugs to prevent or treat the Wuhan coronavirus are currently available.1-[[2,4,6-Tris(Isopropyl)Phenyl]Sulphonyl]-1H-1,2,4-Triazole manufacturer Inceptua has global operations with local offices across Europe, USA, and Asiabenzyl N-[(1Z)-1-amino-1-hydroxyimino-2-methylpropan-2-yl]carbamate supplier ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.4-methylsulfanyl-2-[[3-phenyl-2-(phenylmethoxycarbonylamino)propanoyl]amino]butanoic acid vendor ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.Looking after their staff: Airlines are under pressure from their staff, who obviously want to protect themselves.